Study of rifampicin and silver nanoparticle composite efficacy on rifampicin-resistant Mycobacterium tuberculosis strains

N. Kiria (Tbilisi, Georgia), T. Avaliani (Tbilisi, Georgia), N. Bablishvili (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), G. Phichkhaia (Tbilisi, Georgia)

Source: International Congress 2022 – Advances in the treatment and clinical/surgical management of tuberculosis and NTM

Session: Advances in the treatment and clinical/surgical management of tuberculosis and NTM
Session type: Thematic Poster
Number: 2620

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kiria (Tbilisi, Georgia), T. Avaliani (Tbilisi, Georgia), N. Bablishvili (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), G. Phichkhaia (Tbilisi, Georgia). Study of rifampicin and silver nanoparticle composite efficacy on rifampicin-resistant Mycobacterium tuberculosis strains. 2620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.